PL3556357T3 - Kompozycje pirydostygminy o przedłużonym uwalnianiu - Google Patents

Kompozycje pirydostygminy o przedłużonym uwalnianiu

Info

Publication number
PL3556357T3
PL3556357T3 PL18386007.1T PL18386007T PL3556357T3 PL 3556357 T3 PL3556357 T3 PL 3556357T3 PL 18386007 T PL18386007 T PL 18386007T PL 3556357 T3 PL3556357 T3 PL 3556357T3
Authority
PL
Poland
Prior art keywords
sustained release
pyridostigmine compositions
release pyridostigmine
compositions
sustained
Prior art date
Application number
PL18386007.1T
Other languages
English (en)
Inventor
Ioannis Nikolakakis
Original Assignee
Vianex S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vianex S.A. filed Critical Vianex S.A.
Publication of PL3556357T3 publication Critical patent/PL3556357T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL18386007.1T 2018-04-16 2018-04-16 Kompozycje pirydostygminy o przedłużonym uwalnianiu PL3556357T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18386007.1A EP3556357B1 (en) 2018-04-16 2018-04-16 Sustained release pyridostigmine compositions

Publications (1)

Publication Number Publication Date
PL3556357T3 true PL3556357T3 (pl) 2023-12-04

Family

ID=62091819

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18386007.1T PL3556357T3 (pl) 2018-04-16 2018-04-16 Kompozycje pirydostygminy o przedłużonym uwalnianiu

Country Status (14)

Country Link
US (1) US12527777B2 (pl)
EP (1) EP3556357B1 (pl)
JP (1) JP7313426B2 (pl)
KR (1) KR102858811B1 (pl)
AU (1) AU2019254487B2 (pl)
CA (1) CA3096151A1 (pl)
ES (1) ES2954286T3 (pl)
HR (1) HRP20230971T1 (pl)
HU (1) HUE062809T2 (pl)
MD (1) MD3556357T2 (pl)
PL (1) PL3556357T3 (pl)
RS (1) RS64537B1 (pl)
SM (1) SMT202300264T1 (pl)
WO (1) WO2019201909A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3556357T3 (pl) 2018-04-16 2023-12-04 Vianex S.A. Kompozycje pirydostygminy o przedłużonym uwalnianiu

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10029201A1 (de) * 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
TWI454288B (zh) * 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
CA2947528C (en) 2014-05-01 2023-09-05 Sun Pharmaceutical Industries Limited Extended release suspension compositions
PL3556357T3 (pl) 2018-04-16 2023-12-04 Vianex S.A. Kompozycje pirydostygminy o przedłużonym uwalnianiu

Also Published As

Publication number Publication date
ES2954286T3 (es) 2023-11-21
EP3556357A1 (en) 2019-10-23
US20210128539A1 (en) 2021-05-06
SMT202300264T1 (it) 2023-11-13
JP2021522319A (ja) 2021-08-30
HRP20230971T1 (hr) 2023-12-08
HUE062809T2 (hu) 2023-12-28
AU2019254487A1 (en) 2020-11-19
AU2019254487B2 (en) 2024-07-11
EP3556357B1 (en) 2023-06-07
US12527777B2 (en) 2026-01-20
CA3096151A1 (en) 2019-10-24
JP7313426B2 (ja) 2023-07-24
WO2019201909A1 (en) 2019-10-24
KR102858811B1 (ko) 2025-09-12
EP3556357C0 (en) 2023-06-07
MD3556357T2 (ro) 2023-11-30
KR20200143695A (ko) 2020-12-24
RS64537B1 (sr) 2023-09-29

Similar Documents

Publication Publication Date Title
DK3665237T3 (en) Compositions
GB2586745B (en) Compositions
GB201811312D0 (en) Compositions
SG11202104306XA (en) Compositions
GB201916960D0 (en) Compositions
DK3924442T3 (en) Compositions
IL289125A (en) the vehicles
IL289557A (en) Sustained release formulations of endoxifen
SG11202009259VA (en) Compositions
GB201908396D0 (en) Compositions
GB201719480D0 (en) Compositions
GB201707909D0 (en) Compositions
ZA202101464B (en) Mousse composition
GB201803923D0 (en) Compositions
PL3609464T3 (pl) Kompozycje na bazie ksantohumolu
GB201707454D0 (en) Compositions
IL287762A (en) Controlled-release lipid preparations
GB201919234D0 (en) Compositions
GB2570649B (en) Compositions
GB201805676D0 (en) Compositions
SMT202300264T1 (it) Composizioni di piridostigmina a rilascio prolungato
GB201717712D0 (en) Compositions
GB201703136D0 (en) Compositions
ZA202005658B (en) Compositions
GB201820233D0 (en) Compositions